NeuroPace NPCE
NASDAQ NPCE
$13.05 -0.46 (-3.40%)
At close: Oct 21, 2026 · 4:00 PM EDT

NeuroPace (NPCE) Short term Debt (2020 - 2021)

Updated

NeuroPace's Short term Debt was $3.59 million in Q1 2021, up 75.7% from the prior quarter.

Analysis

NeuroPace (NPCE) Short term Debt (2020 - 2021) Analysis & Trends

At the end of FY2020, Short term Debt at NeuroPace came in at $2.04 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 NeuroPace 446.43 Mn 219.67 Mn 18.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 3.59 Mn
Dec 31, 2020 2.04 Mn
API Access

NeuroPace Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=NPCE&period=max&api_key=YOUR_API_KEY